| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2020 | CRL Charles River Laboratories International, Inc. | Wallman Richard F81 | Director | Buy | 7,200 | $233.20 | $1,679,006.46 | +23.6% | |
| Nov 2, 2020 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 15,000 | $484.09 | $7,261,350.00 | -21.6% | |
| Nov 2, 2020 | A Agilent Technologies, Inc. | Tang Michael61 | SVP, General Counsel, And Sec. | Sell | 4,444 | $102.21 | $454,210.13 | -3.4% | |
| Nov 2, 2020 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 22,000 | $232.38 | $5,112,266.83 | -2.8% | |
| Oct 30, 2020 | BDSX Biodesix Inc | Hutton Scott59 | President &CEO | Buy | 5,500 | $18.00 | $99,000.00 | New | |
| Oct 30, 2020 | BDSX Biodesix Inc | Cowie Robin Harper62 | CFO, Sec?y &Treasurer | Buy | 1,000 | $18.00 | $18,000.00 | New | |
| Oct 30, 2020 | WAT Waters Corp /de/ | Buck Sherry57 | SVP And CFO | Sell | 17,499 | $221.62 | $3,878,128.38 | -82.5% | |
| Oct 30, 2020 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 600,000 | $3.45 | $2,072,820.00 | +0.3% | |
| Oct 30, 2020 | BDSX Biodesix Inc | Watts Charles M | Director | Buy | 2,000 | $18.00 | $36,000.00 | New | |
| Oct 30, 2020 | BDSX Biodesix Inc | Georgantas Robert William III | SVP, Rsrch &Trans'l Science | Buy | 655 | $18.00 | $11,790.00 | New | |
| Oct 30, 2020 | BDSX Biodesix Inc | Massarany Hany | Director | Buy | 7,500 | $18.00 | $135,000.00 | New | |
| Oct 30, 2020 | BDSX Biodesix Inc | Patience John | Director, 10% Owner, Chairman | Buy | 30,000 | $18.00 | $540,000.00 | New | |
| Oct 30, 2020 | BDSX Biodesix Inc | Schuler Jack W45 | Director, 10% Owner | Buy | 277,777 | $18.00 | $4,999,986.00 | New | |
| Oct 30, 2020 | BDSX Biodesix Inc | Strobeck Matthew | Director | Buy | 83,333 | $18.00 | $1,499,994.00 | New | |
| Oct 29, 2020 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 2,300 | $48.74 | $112,095.34 | - | |
| Oct 27, 2020 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 20,000 | $483.88 | $9,677,673.06 | -0.9% | |
| Oct 27, 2020 | GH Guardant Health, Inc. | Talasaz Amirali | Chairman, President And COO | Sell | 93,600 | $106.79 | $9,995,328.67 | -1.7% | |
| Oct 26, 2020 | GH Guardant Health, Inc. | Clark Ian T66 | Director | Sell | 538 | $104.03 | $55,968.14 | -10.4% | |
| Oct 23, 2020 | DHR Danaher Corp /de/ | Comas Daniel L | EVP | Sell | 54,402 | $233.25 | $12,689,037.23 | -8.2% | |
| Oct 23, 2020 | DHR Danaher Corp /de/ | Raskas Daniel67 | Svp-corporate Development | Sell | 28,389 | $234.50 | $6,657,176.85 | -30.7% | |
| Oct 23, 2020 | DHR Danaher Corp /de/ | Lutz Robert S | Svp-chief Accounting Officer | Sell | 24,594 | $233.19 | $5,735,038.51 | -17.5% | |
| Oct 21, 2020 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 17,000 | $49.39 | $839,595.20 | -0.5% | |
| Oct 21, 2020 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 2,200 | $49.09 | $107,990.40 | - | |
| Oct 20, 2020 | PSNL Personalis, Inc. | Abingworth LLP | Former 10% Owner | Sell | 130,486 | $27.66 | $3,609,242.76 | -3.4% | |
| Oct 19, 2020 | PSNL Personalis, Inc. | Abingworth LLP | 10% Owner | Sell | 290,641 | $27.48 | $7,986,081.02 | -3.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.